Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Johnson and Johnson
Dow
Express Scripts
Merck

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203159

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 203159 describes SKYLA, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the SKYLA profile page.

The generic ingredient in SKYLA is levonorgestrel. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 203159
Tradename:SKYLA
Applicant:Bayer Hlthcare
Ingredient:levonorgestrel
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 203159
Physiological EffectInhibit Ovum Fertilization
Medical Subject Heading (MeSH) Categories for 203159
Suppliers and Packaging for NDA: 203159
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SKYLA levonorgestrel INTRAUTERINE DEVICE;INTRAUTERINE 203159 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-422 50419-422-01 1 INTRAUTERINE DEVICE in 1 CARTON (50419-422-01)
SKYLA levonorgestrel INTRAUTERINE DEVICE;INTRAUTERINE 203159 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-422 50419-422-08 1 INTRAUTERINE DEVICE in 1 CARTON (50419-422-08)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INTRAUTERINE DEVICE;INTRAUTERINEStrength13.5MG
Approval Date:Jan 9, 2013TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Nov 13, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Sep 16, 2029Product Flag?YSubstance Flag?Delist Request?
Patented Use:A METHOD OF POSITIONING AN INTRAUTERINE SYSTEM BY HOLDING AN INSERTER HANDLE WITH ONE HAND, ADVANCING THE INSERTER THROUGH THE CERVIX AND INTO THE UTERUS, AND RETRACTING A SLIDER ON THE HANDLE TO RELEASE THE INTRAUTERINE SYSTEM
Patent:  Start TrialPatent Expiration:Apr 1, 2031Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
McKinsey
Colorcon
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.